Loading provider…
Loading provider…
Ophthalmology Physician in Oakland, CA
NPI: 1679014013Primary Employer
East Bay Retina Consultants - Pleasanton
eastbayretina.com
HQ Phone
Get M.D. William's Phone Numberphone_androidMobile
Get M.D. William's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2018 - 2026
MA State Medical License
2022 - 2025
NC State Medical License
2017 - 2018

American Board of Ophthalmology
Ophthalmology
Tufts Medical Center
Fellowship • Surgical Retina and Vitreous
2022 - 2024
Sutter Health/California Pacific Medical Center
Residency • Ophthalmology
2019 - 2022
Wake Forest University Baptist Medical Center
Internship • Internal Medicine
2017 - 2018
Georgetown University
MS • Physiology and Biophysics
2012 - 2013
University of Chicago
BA • Biology
—
Cleveland Medical College, Homeopathic
case.edu
Medical School
Until 2017
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92134Diagnostic imaging of retina | 99 | 105 |
| 2 | 67042Removal of membrane from the retina, pars plana approach | 44 | 44 |
| 3 | 67036Removal of eye fluid (vitreous) between the lens and retina | 32 | 32 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 29 | 31 |
| 5 | 67113Repair of detached retina and drainage of eye fluid between lens and retina | 20 | 21 |
Multimodal imaging of soccer ball-related ocular posterior segment injuries.
Authors: H. Mcdonald, Robert Johnson, Asma Saud, Caleb Ng, Anita Agarwal, J Jumper, Judy Chen, Brandon Lujan, Jayson Koppinger
Journal: Eur J Ophthalmol
Publication Date: 2022-03-09
Heterozygous CRX R90W mutation-associated adult-onset macular dystrophy with phenotype analogous to benign concentric annular macular dystrophy.
Authors: Caleb Ng
Publication Date: 2020-07-22
Lead Sponsor: Kodiak Sciences Inc
Intervention / Treatment: OTHER: Sham Procedure, DRUG: Aflibercept, DRUG: KSI-301
Lead Sponsor: Apellis Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: PEGCETACOPLAN (APL-2)
Lead Sponsor: Hoffmann-La Roche
Collaborators: Chugai Pharmaceutical
Intervention / Treatment: PROCEDURE: Sham Procedure, DRUG: Aflibercept, DRUG: Faricimab